A patient with a VEGF and endostatin producing gastrointestinal autonomic nerve tumour
Open Access
- 27 April 2004
- journal article
- case report
- Published by BMJ in Journal of Clinical Pathology
- Vol. 57 (5) , 536-538
- https://doi.org/10.1136/jcp.2003.012393
Abstract
Tumour associated neovascularisation has been characterised as chaotic and insufficient. This report details the results of the analysis of angiogenic factors in tumour cyst fluid, pleural fluid, and blood from a patient with a gastrointestinal autonomic nerve tumour. The tumour produced vascular endothelial growth factor and endostatin in large quantities, which may explain the dysfunctional angiogenesis and tendency to bleeding seen in this tumour type.Keywords
This publication has 16 references indexed in Scilit:
- Faculty Opinions recommendation of Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system.Published by H1 Connect ,2003
- Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.2002
- Endostatin Blocks Vascular Endothelial Growth Factor-mediated Signaling via Direct Interaction with KDR/Flk-1Journal of Biological Chemistry, 2002
- Endostatin binds to the catalytic domain of matrix metalloproteinase‐2FEBS Letters, 2002
- Plasminogen activators in multiple sclerosis lesions: Implications for the inflammatory response and axonal damageBrain, 2001
- Gastrointestinal Autonomic Nerve TumorThe American Journal of Surgical Pathology, 2001
- Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Interaction of endostatin with integrins implicated in angiogenesisProceedings of the National Academy of Sciences, 2001
- A novel and simple immunocapture assay for determination of gelatinase-b (MMP-9) activities in biological fluids: Saliva from patients with Sjögren's Syndrome contain increased latent and active gelatinase-b levelsMatrix Biology, 1998
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997